<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>13(2)</volume><submitter>Wagner FM</submitter><pubmed_abstract>&lt;h4>Objective&lt;/h4>To evaluate the long-term outcomes of trabeculectomy (TE) surgery in a large cohort with a minimum follow-up of 3 years.&lt;h4>Design&lt;/h4>Retrospective cohort study.&lt;h4>Setting&lt;/h4>University Eye Hospital, Germany.&lt;h4>Participants&lt;/h4>Three hundred and seventy-nine patients with open-angle glaucoma underwent TE with mitomycin C (MMC) between January 2013 and February 2017 with a minimal follow-up of 3 years. Eligible patients were identified via an electronic surgical case register.&lt;h4>Interventions&lt;/h4>All patients had undergone TE with MMC following a set surgical protocol. To assess the influence of cataract surgery following TE, eyes which underwent cataract surgery at least 6 months after TE were matched 1:3 by sex and age to eyes who did not undergo cataract surgery during the follow-up period.&lt;h4>Main outcome measures&lt;/h4>Primary outcome was the proportion of surgical success based on intraocular pressure (IOP), surgical complications, the need for revision surgery, loss of light perception and the need for additional pressure-lowering medication.&lt;h4>Results&lt;/h4>The mean follow-up time was 6 (±0.8, IQR: 5.4-6.5) years. Seventy-three per cent of eyes achieved qualified surgical success at the last follow-up (IOP≥5 mm Hg and ≤18 mm Hg, without surgical complications or complete loss of vision) but necessitated additional medical therapy, complete surgical success with no additional medical therapy was achieved in 69% of eyes. There was no significant difference in the success probability between eyes that had undergone cataract surgery after TE and those that had not (p=0.45).&lt;h4>Conclusions&lt;/h4>The results demonstrate a high and stable success rate of TE after a mean follow-up time of approximately 6 years, that is, not affected by later cataract surgery.</pubmed_abstract><journal>BMJ open</journal><pagination>e068403</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9900049</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Long-term success after trabeculectomy in open-angle glaucoma: results of a retrospective cohort study.</pubmed_title><pmcid>PMC9900049</pmcid><pubmed_authors>Pfeiffer N</pubmed_authors><pubmed_authors>Kianusch K</pubmed_authors><pubmed_authors>Wagner FM</pubmed_authors><pubmed_authors>Hoffmann EM</pubmed_authors><pubmed_authors>Schuster AK</pubmed_authors><pubmed_authors>Stingl J</pubmed_authors></additional><is_claimable>false</is_claimable><name>Long-term success after trabeculectomy in open-angle glaucoma: results of a retrospective cohort study.</name><description>&lt;h4>Objective&lt;/h4>To evaluate the long-term outcomes of trabeculectomy (TE) surgery in a large cohort with a minimum follow-up of 3 years.&lt;h4>Design&lt;/h4>Retrospective cohort study.&lt;h4>Setting&lt;/h4>University Eye Hospital, Germany.&lt;h4>Participants&lt;/h4>Three hundred and seventy-nine patients with open-angle glaucoma underwent TE with mitomycin C (MMC) between January 2013 and February 2017 with a minimal follow-up of 3 years. Eligible patients were identified via an electronic surgical case register.&lt;h4>Interventions&lt;/h4>All patients had undergone TE with MMC following a set surgical protocol. To assess the influence of cataract surgery following TE, eyes which underwent cataract surgery at least 6 months after TE were matched 1:3 by sex and age to eyes who did not undergo cataract surgery during the follow-up period.&lt;h4>Main outcome measures&lt;/h4>Primary outcome was the proportion of surgical success based on intraocular pressure (IOP), surgical complications, the need for revision surgery, loss of light perception and the need for additional pressure-lowering medication.&lt;h4>Results&lt;/h4>The mean follow-up time was 6 (±0.8, IQR: 5.4-6.5) years. Seventy-three per cent of eyes achieved qualified surgical success at the last follow-up (IOP≥5 mm Hg and ≤18 mm Hg, without surgical complications or complete loss of vision) but necessitated additional medical therapy, complete surgical success with no additional medical therapy was achieved in 69% of eyes. There was no significant difference in the success probability between eyes that had undergone cataract surgery after TE and those that had not (p=0.45).&lt;h4>Conclusions&lt;/h4>The results demonstrate a high and stable success rate of TE after a mean follow-up time of approximately 6 years, that is, not affected by later cataract surgery.</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Feb</publication><modification>2024-11-19T23:19:31.833Z</modification><creation>2024-11-19T23:19:31.833Z</creation></dates><accession>S-EPMC9900049</accession><cross_references><pubmed>36737088</pubmed><doi>10.1136/bmjopen-2022-068403</doi></cross_references></HashMap>